Skip to main content
ConductScienceScienceDex

Balveen Kaur

NIH Rank #8314
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8464810Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Pathology
  • Neurosurgery

NIH Funding · FY2024

Linked Award Amount
$1.5M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#8,314
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Balveen Kaur. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Balveen Kaur as a PI. Multi-PI records show the full award amount for context.

  • 1R01NS137577-01R01
    Next generation oncolytic virotherapy targeting AKT and ERK signaling in glioma
    Augusta University
    $563.9K
    award amount
  • 5R01NS127473-03R01
    Next Gen Virotherapy for GBM
    Augusta University
    $513.7K
    award amount
  • 1R61NS128191-01A1R61
    Development of murine glioblastoma model for oncolytic HSV therapy
    Augusta University
    $395.8K
    award amount
  • 5P01CA163205-12P01
    Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
    Brigham and Women's Hospital
    $62K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Balveen Kaur as a PI.

Augusta University
GA
$1.5M
3 grants
Brigham and Women's Hospital
MA
$62K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Augusta University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8314
  5. 2024
    R01 Grant Holder
  6. 2025
    $2M Cumulative Funding
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Balveen Kaur.

Bangxing B Hong
Augusta University
2
shared awards
E. Antonio Chiocca
Brigham and Women's Hospital
2
shared awards
Joseph C Glorioso
Brigham and Women's Hospital
2
shared awards
Keith Lloyd Ligon
Brigham and Women's Hospital
2
shared awards
Michael A Caligiuri
Brigham and Women's Hospital
2
shared awards
William F. Goins
Brigham and Women's Hospital
2
shared awards
Xiaokui Mo
Brigham and Women's Hospital
2
shared awards

Explore further

Find collaborators for Balveen Kaur

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →